qGenomics (Quantitative Genomic Medicine Laboratories) at ASHG 2026

Oct 20–24, 2026 Montréal, Canada ~7.5k attendees Website

qGenomics (Quantitative Genomic Medicine Laboratories) at ASHG 2026 in Montréal: 1 presentation (1 poster).

Organization	ASHG 2026 Attendance
qGenomics (Quantitative Genomic Medicine Laboratories) Esplugues de Llobregat, Barcelona	1 Genetic Diagnostics Manager
qgenomics.com\|LinkedIn Subsidiary~32 people Diagnostic laboratory selling rare-disease genetics, array analysis, and carrier screening to healthcare professionals and patients. Was formally merged into parent company Veritas Intercontinental, completing its integration as a separate legal entity. › Was formally merged into parent company Veritas Intercontinental, completing its integration as a separate legal entity. 2026-07 · source Parent Veritas appointed Lluís Armengol as chief scientific officer, strengthening scientific leadership across the combined rare-disease testing business. 2025-11 · source Was acquired by Veritas Genetics to expand rare-disease, carrier-screening, and array testing services in Spain. 2025-09 · source Source: company newsroom	Poster Wed Oct 21 2:30 pm Part of Mendelian Phenotypes Poster Wednesday Session Increasing diagnostic yield in patients with intellectual disability through exome reanalysis and complementary techniques Exhibit & Poster Hall · Board 1103W Collaborators: Universitat de Barcelona Intellectual and developmental disabilityExome/genome sequencingRNA-seqEpigenetics

Organization

ASHG 2026 Attendance

qGenomics (Quantitative Genomic Medicine Laboratories)

Esplugues de Llobregat, Barcelona

1 Genetic Diagnostics Manager

qgenomics.com|LinkedIn

Subsidiary~32 people

Diagnostic laboratory selling rare-disease genetics, array analysis, and carrier screening to healthcare professionals and patients.

Was formally merged into parent company Veritas Intercontinental, completing its integration as a separate legal entity.

›

Was formally merged into parent company Veritas Intercontinental, completing its integration as a separate legal entity.

2026-07 · source

Parent Veritas appointed Lluís Armengol as chief scientific officer, strengthening scientific leadership across the combined rare-disease testing business.

2025-11 · source

Was acquired by Veritas Genetics to expand rare-disease, carrier-screening, and array testing services in Spain.

2025-09 · source

Source: company newsroom

Poster

Wed Oct 21
2:30 pm

Part of Mendelian Phenotypes Poster Wednesday Session

Increasing diagnostic yield in patients with intellectual disability through exome reanalysis and complementary techniques

Exhibit & Poster Hall · Board 1103W

Collaborators: Universitat de Barcelona

Intellectual and developmental disabilityExome/genome sequencingRNA-seqEpigenetics

Instantly find 20 buyers from qGenomics (Quantitative Genomic Medicine Laboratories)

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the American Society of Human Genetics. Submit a correction